Adult T-cell leukemia other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Adult T-cell leukemia}} | {{Adult T-cell leukemia}} | ||
{{CMG}}; {{AE}}{{HL}} | |||
==Overview== | |||
==Other Diagnostic Studies== | |||
===Skin Biopsy=== | |||
===Bone Marrow Biopsy=== | |||
===Cytogenetic Tests=== | |||
* '''[[Karyotyping]]''' | |||
* [[ | * '''[[Fluorescent in situ hybridization]]''' | ||
==References== | ==References== | ||
Line 12: | Line 17: | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Pathology]] | [[Category:Pathology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] |
Revision as of 15:20, 25 January 2016
Adult T-cell leukemia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Adult T-cell leukemia other diagnostic studies On the Web |
American Roentgen Ray Society Images of Adult T-cell leukemia other diagnostic studies |
Risk calculators and risk factors for Adult T-cell leukemia other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]